7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square

NEWS

February 14, 2020

- Contera Pharma is preparing for public offering in KOSDAQ -

Bukwang has recently received the investigational new drug...

January 31, 2020

- Kalbe International to take on sales in 2 approved countries

Bukwang Pharmaceutical Co., Ltd (Bukwang) announced that i...

January 10, 2020

Bukwang Pharmaceutical Co., Ltd. (Bukwang) announced that JM-010 has been administered to the first patient in phase 2 s...

January 2, 2020

Bukwang Pharmaceutical announced that it has entered into an agreement with Sanofi-Aventis Korea to co-promote an ARB cl...

November 13, 2019

ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor based therapies for neurodegenerative diseas...

September 30, 2019

ASLAN spins out pre-clinical assets in joint venture with Bukwang to form JAGUAHR Therapeutics with Bukwang investing up...

July 25, 2019

Dr Jean Bousquet, a renowned expert in pulmonary allergy, has delivered a keynote lecture on the next generation guideli...

July 10, 2019

  • 3 million dollars invested by Medici Investment

  • European Clinical phase 2 study of JM-010 to treat dyskinesia i...

July 5, 2019

The sales of Dexid for diabetic polyneuropathy, Legalon for liver disease, and Entecavir for chronic hepatitis B are boo...

July 3, 2019

The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based B...

Please reload

Recent
Please reload

|    ​Korean    |